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Abstract
Background: New Canadian policy to regulate natural health products (NHPs), such as herbs and
vitamins were implemented on January 1st, 2004. We explored complementary and alternative
medicine (CAM) practitioners' perceptions of how the new regulations may affect their practices
and relationships with patients/consumers.
Methods: This was an applied ethnographic study. Data were collected in fall 2004 via qualitative
interviews with 37 Canadian leaders of four CAM groups that use natural products as a core part
of their practises: naturopathic medicine, traditional Chinese medicine (TCM), homeopathic
medicine and Western herbalism. All interviews were transcribed verbatim and coded
independently by a minimum of two investigators using content analysis.
Results: Three key findings emerged from the data: 1) all CAM leaders were concerned with issues
of their own access to NHPs; 2) all the CAM leaders, except for the homeopathic leaders,
specifically indicated a desire to have a restricted schedule of NHPs; and 3) only naturopathic
leaders were concerned the NHP regulations could potentially endanger patients if they self-
medicate incorrectly.
Conclusion: Naturopaths, TCM practitioners, homeopaths, and Western herbalists were all
concerned about how the new NHP regulations will affect their access to the products they need
to practice effectively. Additional research will need to focus on what impacts actually occur as the
regulations are implemented more fully.
Background
Studies in Canada, the United States and the United King-
dom indicate that people who use natural health products
(NHPs) like herbal medicines are more likely to do so as
a component of self-care than upon the recommendation
of a complementary/alternative medicine (CAM) practi-
tioner [1-3]. However, in 2003, almost seven percent of
Canadians reported seeing some type of CAM practitioner
(chiropractor, massage therapist, acupuncturist, homeo-
path, naturopath, herbalist or other)[4]. When individu-
als do visit CAM practitioners, they are often advised
about the use of NHPs for their particular conditions or
problems, and NHPs are an important aspect of many
CAM practitioners' practices.
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from previous status as foods with relatively unencum-
bered access by those who use NHPs as part of a therapeu-
tic regime, to the current status where these products are
regulated as a special category of drugs, with more strict
control over their manufacturing, labelling, and indica-
tions for use. As part of the Health Products and Food
Branch of Health Canada, the Natural Health Products
Directorate (NHPD) is the regulating authority for NHPs
for sale in Canada. The NHPD's role is "to ensure that
Canadians have ready access to NHPs that are safe, effec-
tive and of high quality, while respecting freedom of
choice and philosophical and cultural diversity" [5].
Although the new regulations do not directly impact the
practice of health care practitioners (some of whom are
unregulated, and some whose regulations fall under pro-
vincial jurisdiction), practitioners who use NHPs as part
of their practice may be indirectly affected. We explore
CAM practitioners' (naturopaths, traditional Chinese
medicine (TCM) practitioners, Western herbalists and
homeopaths) perceptions of how the new Natural Health
Product Regulations (referred to in this paper as NHP reg-
ulations) may affect their practices. We also analyze the
commonalties and differences in perceptions between
these CAM groups' perceptions of the impact of the NHP
regulations.
The NHP regulations
In Canada, as of January 1st, 2004 the federal government
regulates NHPs, such as herbs, vitamins and minerals.
Under the new NHP regulations, by definition, a NHP
must be safe for over-the-counter (OTC) use; that is, the
label and package insert must provide enough informa-
tion for a consumer to safely and effectively use the prod-
uct without consulting a health care provider [6]. NHPs
are defined in the regulations as herbs, vitamins, minerals,
essential fatty acids and homeopathics which are used to
prevent, diagnose or treat disease, restore or correct func-
tion or maintain or promote health that are endorsed for
self-care purposes [6].
The new regulations stipulate that all NHPs sold in Can-
ada require product licenses. The intent of requiring pre-
market approval is to provide a mechanism for assessing
and managing the benefits and risks associated with the
use of NHPs [7,8]. The regulations set out the require-
ments for submitting an application for a product license,
which includes the quantity of the medical ingredients,
the purpose for which the NHP is intended to be sold as
well as safety and efficacy data that supports the product
[9]. Product license submissions must provide a compre-
hensive review of the evidence for the safety and efficacy
of the product including evidence of traditional uses
where appropriate [10]. Since up to 50,000 NHPs were
already being sold in Canada when the regulations
became law on January 1, 2004, Health Canada has pro-
vided a six year transition period during which companies
must submit product license applications for all existing
products. Products without licenses may continue to be
sold during the transition period, but enforcement actions
[9] will be taken against non-compliant companies that
miss the required deadlines stipulated for specific product
classes during this period [11].
NHP companies are also required to meet good manufac-
turing practice standards [12] and should have applied for
a site license [13] by December 31, 2006. Only manufac-
turers, packagers, labellers and importers that meet these
standards will be allowed to continue to operate in Can-
ada.
In this article, we discuss the perceptions held by leaders
of four CAM groups regarding how the implementation of
these regulations may impact their practices. Our inter-
views took place in the fall of 2004 when very little had
actually changed in terms of practice or access in the Cana-
dian NHP market place. Therefore, in this article, CAM
leaders' perceptions of what might happen because of the
new NHP regulations are outlined (as opposed to what
has actually happened or is actually happening).
The CAM practitioner groups
Four CAM practitioner groups are included in the current
study. These practitioner groups were chosen because
NHPs are a core component of their practises in Canada.
Although many other practitioners may recommend
some types of NHPs (e.g., chiropractors), our focus was
on those practitioner groups whose scope of practise is
largely dependent on their ability to use NHPs.
Canadian naturopathic practitioners use a combination
of clinical nutrition, botanical (herbal) medicine, homeo-
pathic medicine, physical treatments, acupuncture, Asian
medicine and lifestyle counselling to stimulate the body's
own self-healing abilities [14]. Naturopathic medicine is
regulated in four Canadian provinces. Traditional Chinese
medicine (TCM) includes a vast range of practices such as
acupuncture, herbal medicine, tuina massage and diet
therapy [15]. The regulation of TCM varies considerably
across Canada. The three fundamental practices of Cana-
dian Western herbalism are: (i) the use of whole plants to
treat and prevent illness; (ii) the combination of herbs
and (iii) the individualization of herbal combinations in
treatment [15,16]. Western herbalists employ a combina-
tion of North American and European herbs [16]. Western
herbalism is not regulated in any Canadian province. The
practice of homeopathy is based on three fundamental
principles: the laws of similars (like cures like), individu-
ality (examine each patient's symptoms, physical/mental/
emotional, individually) and the use of infinitesimalPage 2 of 8
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potent it is) [17,18]. Canadian homeopathic practitioners
are also not regulated in any Canadian province.
The new regulations for NHPs represent an emergent
instrument that has the potential to (re)shape the behav-
iour of several groups who have an interest in NHPs. This
includes the various practitioner groups, described above,
who may previously have had greater freedom in their
uses of NHPs in professional practice; and consumers,
who may perceive that they now have more open access to
NHPs, because there is more information on the over-the
counter labels. Further, the new Regulations have the
potential to create new norms of behaviour. That is,
although policies may be initially imposed to change pre-
vious practices and behaviours, new practices are eventu-
ally internalized as norms that influence people to think,
feel and act in particular ways [19,20]. The practitioner
groups who include NHPs as an integral part of their pro-
fessional health practice are likely to be impacted by these
new orientations and practices related to NHPs. In this
study, we describe these groups' perceptions of how the
new NHP regulations are likely to affect their practice, and




The design used in this qualitative study is an applied eth-
nography [21,22]. An applied ethnography is a qualitative
research approach that seeks to interpret the meanings of
beliefs and behaviours in the context of social/cultural
worlds in which individuals are immersed. While a tradi-
tional ethnography is focused on describing and interpret-
ing a cultural or social group or system, an applied
ethnography is focused on a research population that is
defined by some larger social problem, and seeks to
describe and expose fields of experience in which mean-
ing is routinely contested. CAM practitioners' role in the
Canadian health care system is currently contested. Most
CAM definitions describe CAM as those practices that are
not part of the dominant health care system. Thus the reg-
ulation of NHPs, which are a significant part of the work
of many CAM practitioners, is likely to have a significant
impact on CAM practices, potentially resulting in the
"mainstreaming" of some CAM practitioners. For exam-
ple, CAM practitioners rely on NHPs (now regulated as
therapeutic products) similar to medical doctors who rely
on pharmaceutical products. Or, given the new require-
ments that NHPs are safe for OTC use, these groups may
feel their role in advising the public about the safe and
appropriate use of NHPs will be usurped.
Data collection
We conducted key informant interviews [22] with formal
and informal leaders of CAM groups in Canada: Western
herbalism (n = 9), naturopathy (n = 10), traditional Chi-
nese medicine (n = 8), and homeopathy (n = 10). Formal
leaders (e.g. president, chair, head or director) were pur-
posively selected from a list associations, schools and
journals to ensure the inclusion of a range of leaders who
reflect different segments of each group. Informal leaders
were identified by other key informants as part of a
"snowball" sampling technique [22]. At the start of the
interview, written and informed consent was obtained
from each participant. Interviews continued until it
became apparent that saturation of the key themes was
reached [22]. See Appendix 1 for a copy of the interview
guide. This study received ethics approval from the Office
of the Vice-President, Research and Associate Provost, Eth-
ics Review Office at the University of Toronto.
The study participants had been practising in Canada
from 5 to 35 years. Some participants had formal CAM
training from schools in Canada, Europe or China, while
others received training in the form of an apprenticeship.
All 37 CAM leaders when contacted agreed to participate
in the study, with the exception of 1 TCM leader who had
retired and 1 homeopathic leader who felt he was not well
versed in the regulations to participate in an interview.
The TCM leader did however, recommend that one of his
colleagues be contacted, and this informant was later
interviewed. Based on the overlap in recommendations
we had for participants, we are confidant that we were suc-
cessful in recruiting key CAM leaders whose opinions
reflect the four groups' professional opinions about the
new regulations.
Analysis
In order to explore CAM leaders' perceptions of the NHP
regulations, interpretative content analysis was used to
evaluate their responses to the semi-structured interview
questions [23]. The analysis involved identifying themes,
sub-themes, and relationships among these. All transcrip-
tions of the semi-structured interviews were entered into
Nvivo, a qualitative computer software program [24],
used to manage text-data and facilitate our analysis. Each
transcript was coded independently by at least two inves-
tigators. Interview transcripts were divided into simple
single-topic themes, called child-themes. Where relevant,
child-themes were placed in a topic category or parent-
theme, based on its content and an evident relationship
between the parent- and child-theme [22].Page 3 of 8
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Naturopathic leaders' concerns about the NHP 
regulations
In general, naturopathic leaders viewed the new NHP reg-
ulations in a positive light. They explained that the public
will have more information to make good decisions about
self-selected products and that they can be confident that
NHPs are meeting specific quality standards. However,
the participants expressed some concerns relating to
patient safety. They argued the public should not self-
diagnose and self-prescribe for certain conditions and
that, without practitioner guidance, the use of some herbs
may put patients at risk. The cardiac herb, hawthorn, is a
good example of this: "As soon as you take hawthorn, you
have to assume that there is a cardiac problem and they
should be consulting somebody".
Related to this, the naturopath participants feared that
high-risk NHPs would be taken off the market and placed
on prescription schedules (meaning that CAM practition-
ers would no longer have access to those NHPs in prac-
tice). Many explained that naturopaths should have access
to a list or schedule of NHPs that were considered high-
risk:
"we were hoping there would be some way by which we
could prescribe but that sort of fell through....we were
hoping that there would be a separate category just for us
or just for providers like us".
Even though the participants would like access to a list of
high-risk products, they understood that trying to deter-
mine who would have access to "prescribe" or "recom-
mend" these products to patients would be difficult to
determine since most CAM practitioners are either not
regulated at all in Canada or are not regulated consistently
across all provinces:
"It is hard to find a place for our practice given that there
is not consistency across the provinces with regulation of
naturopathic doctors...so, it is difficult when you are deal-
ing with a federal regulation: how does it translate into
your practice in a province where naturopaths are regu-
lated [i.e., Ontario] and in other provinces where they are
not?"
Naturopaths were very inclusive in their ideas about who
might have the right to access products on this hypotheti-
cal restricted schedule. Only one of the ten naturopathic
leaders we interviewed argued that no one else besides
naturopaths should have such access. The naturopaths
believed any health care practitioner providing evidence
of appropriate training should have access to these high-
risk products. For example, the naturopaths agreed that it
would be unfair to restrict qualified TCM practitioners'
access to TCM NHPs. However, the naturopaths acknowl-
edged that as long as TCM practitioners remain unregu-
lated in most Canadian provinces, it would be difficult to
determine what constitutes a qualified TCM practitioner.
Western herbalist leaders' concerns about the NHP 
regulations
In contrast to the naturopathic leaders, Western herbalist
leaders were not concerned that the NHP regulations
would increase the rate of, or risks associated with, self-
medication. One participant explained that herbalists
want the public to be able to look after themselves:
"I like the idea that if it was a cold or an insect bite that
people should be able to know what to do and we have
lost a lot of that....sometimes people need to know how to
use things....we have to be able to explain on the label
clearly what this is known to be good for and the proper
usage of it".
"it's making people, the public more aware of the need for
consultation with health professionals. By making, say,
that claim on the bottle, it's letting people know that sim-
ply buying an over-the-counter remedy, it's not necessar-
ily enough. So I think it's heightening awareness
somewhat in the public's eye...OTCs may not be the best
choice, or alone aren't the best choice, so it's sending them
a little further along the line potentially to the doorstep of
a natural health practitioner."
Another participant predicted that the regulations will
either have no impact on self-medication or the regula-
tions might even encourage people not to self-medicate:
"it may actually reduce self-medication when they start to
see all of the contraindications and warnings on
labels....the regulations will probably have no effect or
possibly reduce people's self-medicating". One partici-
pant specified that for serious conditions (i.e., cancer) the
public should be encouraged to consult an appropriate
practitioner, whether conventional or complementary.
Like the naturopaths, several herbalist leaders thought it
would be beneficial if herbalists had access to some high-
risk products that were not directly accessible to the pub-
lic. One herbalist practitioner made it clear that if there
was such a schedule, it should only be accessible to regis-
tered herbalists, and not only to pharmacists, as is the case
currently for some drugs. The herbalists were less clear
about which other CAM practitioner groups should have
access. Western herbalist leaders realized that their unreg-
ulated status would make it difficult to determine if they
might be qualified to prescribe NHPs. However, Western
herbalists specifically indicated that they did not see phar-
macists as appropriate gate-keepers of NHPs, given their
lack of knowledge about herbs.Page 4 of 8
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NHP regulations
TCM leaders did not think that the NHP regulations
would increase or discourage self-medication use among
the public. According to one TCM leader:
"there may be less of a tendency for people to go and self-
treat, unless they are Chinese and unless it has been part
of their tradition and culture....I don't think many people
would walk in and just buy something off the shelf. It
depends on how they are going to be sold and where they
are going to be allowed to be sold".
Many TCM leaders were concerned about how NHPs, typ-
ically used by TCM practitioners, would be labelled. Some
herbs or NHPs may have both Western and TCM uses.
There was some uncertainty about whether or not both
TCM and Western uses of an herb will be labelled on
NHPs. TCM leaders were concerned that their unique
knowledge will be ignored if only the Western use of the
herb is described on the label. However, if the TCM uses
were listed on the bottle they might be taken out of the
context of the TCM philosophy which these leaders
described as problematic: "for example, if the label just
says headaches, but it may not treat all headaches, you
know, it might treat only one particular kind of head-
ache".
TCM leaders also feared that the Natural Health Products
Directorate (NHPD) may over-regulate NHPs, taking
some high-risk products off the market. Like the other
leaders, they suggested a restricted schedule of high-risk
NHPs, similar to conventional drugs:
"I think that there are some herbs that could be deemed,
you know, toxic or dangerous or should only be pre-
scribed by a practitioner and dispensed by a phar-
macy....that would protect the public and give
practitioners access to that particular product".
Like the naturopaths and the Western herbalists, deter-
mining who should have access to those products was
identified by the TCM leaders as potentially very compli-
cated. However, the TCM leaders described that only TCM
practitioners should have access to high-risk TCM NHPs,
because they are the only qualified practitioners to handle
these high-risk products: "naturopaths have also done a
little bit of traditional Chinese medicine... it seems unfair
that they should be allowed to prescribe something that
they don't have extensive knowledge in".
Homeopathy leaders' concerns about the NHP regulations
Similar to the TCM leaders, the self-medication issues
were of no concern for homeopathic leaders:
"I think most people realize that certain things should not
be used without consulting a practitioner, because of the
toxicity of the products. For example, [regarding] Bella-
donna, the label would explain what would happen, what
they're dealing with...so I don't think it [self medication]
will be much of an issue.
Although they did not advocate a "restricted schedule" of
products like the other practitioners, the homeopathic
leaders were concerned about maintaining access to
homeopathic products. This concern was related to the
homeopaths' views that personnel within the NHPD may
not be sufficiently competent to deal with homeopathic
products. For example, three homeopathic leaders
described what they perceived as the lack of homeopathic
experience and homeopathic education among members
of the NHPD. There were numerous references to NHPD
members' lack of understanding of the principles of
homeopathy. The homeopathic leaders explained that
during the development of the regulations, they had to
continuously reiterate these concerns to the members of
the NHPD. One participant explained that the individuals
with homeopathy expertise working at the NHPD do not
in his opinion have sufficient education and experience in
homeopathy.
Discussion
All CAM practitioners were concerned with issues of their
own access to NHPs, but specific concerns differed
between groups. For example, all CAM groups included in
the study, with the exception of the homeopathic leaders,
specifically indicated a desire to have a restricted schedule
of NHPs that would be available to CAM practitioners and
secondly, the naturopathic leaders were the only group
concerned that the NHP regulations could potentially
endanger patients if they self-medicate incorrectly with
NHPs because of unrestricted access to some NHPs.
Access issues dominated all the interviews. A restricted
schedule of NHPs that would be available to CAM practi-
tioners was discussed by many as a possible way to protect
practitioners' access to NHPs, which are necessary for their
practises even if some NHPs are no longer available to the
general public. The naturopaths expressed a desire for a
restricted list of NHPs made available to themselves and
other qualified practitioners. Naturopaths are regulated in
four Canadian provinces and having the power to "pre-
scribe" from such a list could be seen as a way to legiti-
mize their knowledge claims. TCM leaders also hoped to
have access to high-risk NHPs and some even argued that
if they are successful in becoming regulated they would
have access to those products even if they were in a
restricted schedule. Western herbalists saw great value in
having such a list, but worried that, because of their unreg-
ulated status, they may not have access to it and homeo-Page 5 of 8
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important.
There were conflicting views regarding who should have
access to high-risk products, and where they should be
available. Based on our findings, CAM practitioners
viewed themselves as the legitimate gatekeepers of NHPs
(based on their unique knowledge base) and they
explained that conventional practitioners' access to these
products should be limited. It would be interesting to
determine if physicians, who are the gatekeepers of pre-
scription medications, would agree with this. Another
important consideration is that some drugs in Canada are
restricted to sales in pharmacies (i.e., the patient must
access the drug through a pharmacist). If certain NHPs
were to be restricted to sale in pharmacies, the public
would have to consult a pharmacist to receive them. No
CAM group suggested this as a viable option.
The naturopathic leaders were the most inclusive in
regards to which practitioners should have access to any
restricted schedule of NHPs. Their perspective could be
based on their education (i.e., they learn from a range of
philosophies including Western herbalism, TCM, home-
opathy, manipulation, nutrition etc.). The naturopathic
practitioners' inclusiveness may also be a result of the fact
that they felt more involved in, and in control of, the
major components of the development and implementa-
tion of the NHP Regulations because naturopaths had
greater representation on the NHPD than any other CAM
practitioner group (i.e., the Director General of the NHPD
is a naturopathic practitioner). This may have given the
naturopaths confidence that the implementation of the
NHP regulations will not threaten their core practices, and
indeed, may have allowed the leaders of naturopathy to
focus on details that may strengthen and further legiti-
mize their role in Canadian health care.
Naturopaths were the only group that expressed a concern
that once the new regulations are fully implemented,
members of the public may no longer feel the need to con-
sult either a naturopath or any other practitioner. This
appeared to be indicative of a concern about restricted
access and professional "turf", based on naturopaths'
claims to having specific knowledge of, and expertise
around the uses of NHPs. The regulation of NHPs as over-
the-counter products appears to suggest disregard for
naturopath's claims to knowledge and its unique
approaches to health promotion or treatment of illness. It
is notable that the naturopath leaders' concerns about "off
label" use, or inappropriate use of NHPs were similar to
the conventional literature on OTC use where it has been
argued that selecting the appropriate OTC medication can
be very confusing (and potentially harmful) for consum-
ers, particularly because of numerous emergent "line
extensions", presented as "new" products [25].
In contrast to the concerns of naturopaths, Western herb-
alist leaders were not concerned that the NHP regulations
would encourage self-medication use and this could
potentially be related to their philosophy of care and prac-
tice. Western herbalists reported encouraging their
patients to learn to heal by themselves without the help of
a practitioner.
Both TCM and homeopathy leaders did not identify
changes in self-medication behaviour as a potential out-
come of the new regulations. It appeared that neither
group viewed self-medication as a threat to their practice.
This may be because the complex theories that govern
TCM and homeopathy product choice make these prod-
ucts less accessible to the general public. All but a few
"first aid" remedies require the practitioner's guidance for
effective use. TCM and homeopathic products were previ-
ously available directly to consumers, but the pubic
lacked the expertise to self-select in most cases. TCM and
homeopathic leaders did not identify the new informa-
tion required on NHP labels as a threat to their expert
knowledge. However, TCM leaders were concerned that
TCM NHPs may be labelled inappropriately in that they
would not accurately reflect TCM philosophy.
The findings suggested that these groups' diverse practices
are not usefully combined into a single entity called CAM,
which is defined in comparison to the dominant medical
system. There was diversity between the different CAM
groups, just as there is between "CAM" and conventional
medicine. In fact, one of the reasons it was so difficult to
define CAM is the lack of uniform underlying beliefs,
principles or practices that are common to all CAM prac-
titioner groups. For example, the Western herbalists,
homeopaths and TCM leaders that we spoke to were con-
cerned about the fact that a naturopath was the head of
the Directorate and that their specific practice issues may
not be addressed. Just because these groups differed sig-
nificantly from conventional medicine, does not mean
their interests were the same. Although the naturopaths,
homeopaths, Western herbalists and TCM practitioners
practice largely outside the conventional health care sys-
tem, they were all fighting for space within that system.
Policy makers should not ignore the nuances of that strug-
gle.
This is an exploratory qualitative study in which we pro-
vided an in-depth examination of CAM leaders' percep-
tions of the NHP regulations and the perceived impact on
their professional groups. We spoke to the key naturo-
pathic, homeopathic, Western herbalist and TCM leaders
in Ontario and we believe the findings are an accuratePage 6 of 8
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to leaders in other jurisdictions or to other "CAM" provid-
ers besides the four groups in this study. Finally, there is
no official list of Canadian CAM associations and schools.
Therefore, some CAM associations and schools may not
have been included in the list of CAM associations and
schools that was developed prior to data collection. How-
ever, a snowball sampling technique was employed,
which allowed us to capture some associations, and
schools that were initially missed. Interviews continued
until key themes were saturated.
As the regulations continue to be implemented in Can-
ada, it will be important to explore the actual impact of
these regulations on the naturopathic, homeopathic,
Western herbalist and TCM practices that were the focus
of this study. Of particular relevance will be whether or
not these groups actually lose access to particular NHPs
and if so how they handle the loss of products, and what
impact it has on their practice or access to products. Rank
and file practitioner opinions of the NHP regulations will
also be important to research because they may differ sig-
nificantly from the opinions of the leaders, given at times,
the lack of cohesion among these groups, as described by
Welsh et al.[26].
Conclusion
Naturopaths, TCM practitioners, homeopaths, and West-
ern herbalists were all concerned about how the new NHP
regulations will affect their access to the products, which
they need to practice effectively. The new regulations
define NHPs as over the counter products, thus CAM lead-
ers, particularly the naturopathic leaders, were concerned
that their role as health care providers will be limited.
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APPENDIX 1
Semi-structured interview questions
1. How did you become interested in naturopathy, homeop-
athy, traditional Chinese medicine or Western herbalism and
what are some of the guiding principles that inform your
practice?
2. What do you know or what have you heard about the
new NHP regulations?
Probes
a) Why do you feel the new NHP regulations were devel-
oped?
b) Where you consulted in the development of the new
NHP regulations by the Natural Health Product Directo-
rate?
c) Have you attended any information sessions or semi-
nars on the new regulations?
d) Have you found information on the new NHP regula-
tions to be readily available?
3. What do you think about the information you have
received regarding the new regulations?
4. How do you feel these regulations will impact the goals,
practices and philosophical traditions of homeopathy?
naturopathy? traditional Chinese medicine? or Western herbal
medicine?
Probes
a) What are your thoughts regarding the statement that "it
appears that CAM practitioners who manufacture large
batches of NHPs at one time to treat numerous patients
will have to apply for site licenses and product licenses
under the new regulations".
b) What are your thoughts about whether it should be
stated on the label of certain NHPs that a homeopathic,
naturopathic, traditional Chinese medicine or Western herbal
medicine practitioner should be consulted when taking
this product?
c) In regards to the current list of NHPs listed on Schedule
1 of the new regulations, do you feel there should be otherPage 7 of 8
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under other Acts?
d) What are your feeling surrounding the possibility that
homeopathic, naturopathic, traditional Chinese medicine or
Western herbal medicine practitioners will loose access to
certain NHPs as a result of the new regulations?
e) Homeopathic Leaders: What are your feelings sur-
rounding the fact that homeopathic products will keep
their 8-digit DIN number as oppose to transferring to a
natural product number (NPN)?
f) Naturopathic Leaders: How do you feel about the inclu-
sion of NHPs in the proposed scope of practice stated in
the 2001 HPRAC report?
5. How do you foresee these regulations impacting the
ability of homeopathic, naturopathic, traditional Chinese
medicine or Western herbal medicine practitioners to prac-
tice in a manner consistent with their philosophical tradi-
tions?
6. According to the government, the NHP regulations are
suppose to bring improved access to safe NHPs, while
respecting Canadian's freedom of choice and cultural
diversity. What are your thoughts about this statement?
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